1h Free Analyst Time
SummarySpeak directly to the analyst to clarify any post sales queries you may have.
The publisher's Medical Devices sector report, “Drug Eluting Stents (DES)-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
DES release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Drug Eluting Stents (DES) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents5 Drug Eluting Stents (DES) Companies and Product Overview6 Drug Eluting Stents (DES)-Recent Developments7 Appendix
2 Introduction
3 Products under Development
4 Drug Eluting Stents (DES)-Pipeline Products under Development by Companies
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Advanced Bifurcation Systems Inc
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- B. Braun Melsungen AG
- Biosensors International Group Ltd
- Biotronik AG
- Biotronik SE & Co KG
- Boston Scientific Corp
- Cardionovum GmbH
- Columbia University
- Concept Medical Inc
- Cordis Corp
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- I.B.S. S.p.A.
- InspireMD Inc
- JW Medical Systems Ltd
- Kaneka Corp
- Liaoning Biomedical Materials R&D Center Co Ltd
- MangoGen Pharma Inc
- Medinol Ltd
- Medtronic Plc
- MicroPort Scientific Corp
- MIV Therapeutics Inc
- NuVascular Technologies Inc
- Relisys Medical Devices Ltd
- REVA Medical Inc
- Shanghai Bio-heart Biological Technology Co Ltd
- Sino Medical Sciences Technology Inc
- Stentys SA
- Svelte Medical Systems Inc
- Terumo Corp
- TissueGen Inc
- University of Strathclyde
- VasoTech Inc.